Previous close | 44.80 |
Open | 0.00 |
Bid | 0.00 x 0 |
Ask | 0.00 x 0 |
Day's range | 0.00 - 0.00 |
52-week range | |
Volume | |
Avg. volume | 1,232 |
Market cap | 11.509M |
Beta (5Y monthly) | 0.52 |
PE ratio (TTM) | 0.29 |
EPS (TTM) | 1.55 |
Earnings date | 06 Mar 2024 |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | N/A |
PRESS INFORMATIONHeading: 2023 annual results Nanterre, March 6, 2024 (after trading) Net profit (group share) up 11.5% in 2023 Financial statements at December 31 (1)20222023Revenues665.4741.2Business operating profit (2)77 (11.6%)81.5 (11%)Operating profit72.9 (11%)75.9 (10.2%)Financial profit04.9Tax on earnings(21.1)(22.2)Net profit51.8 (7.8%)58.6 (7.9%)- of which, group share44.349.4Free cash flow (3)37.651.6Cash and cash equivalents (net of financial debt) (4)271.8290.4Staff at year-end6,40
PRESS INFORMATIONHeading: 2023 annual revenues Nanterre, February 7, 2024 (after trading) 11.1% organic growth in 2023 (being audited, in € millions)20222023Growthof which organicRevenues665.4741.2+ 11.4%+ 11.1% Achievements Revenues for 2023 exceeded forecasts and totaled €741.2 million (+ 11.4%). Growth in Q4 amounted to + 9%. Consulting, digital projects, data, cybersecurity, cloud and improving “employee experience” continue to drive growth. Among our activities, the sovereign and trusted cl
PRESS INFORMATIONHeading: 3rd quarter 2023 revenues Nanterre, November 8, 2023 (after trading) Organic growth up 12.3% over the first nine months of the year (not audited, in millions of euros)20222023growthof which organic3rd quarter revenues158.9177+ 11.4%+ 11%Total as at the end-September486545.7+ 12.3%+ 12.3% Achievements NEURONES posted double-digit organic growth in the 3rd quarter, as it has done over the nine-month period as a whole. Employee turnover remained high, reflecting continued